Search Clinical Trials
583,695 trials
ID
Status
Phase
Title
Sponsor
NCT07575217
Mail-in HPV Screening Program in NJRutgers, The State University of New JerseyNot Yet RecruitingNot Applicable
NCT07575217Not Yet Recruiting
Not Applicable
Mail-in HPV Screening Program in NJRutgers, The State Univer...
NCT07574918
Measuring Nasal Airway Changes After VivAer Treatment Using AI Analysis.Aerin MedicalNot Yet RecruitingNot Applicable
NCT07574918Not Yet Recruiting
Not Applicable
Measuring Nasal Airway Changes After VivAer Treatment Using AI Analysis.Aerin Medical
NCT07575061
A 15-year Cohort Study on Risk Factors of Mortality in Patients With Intestinal TuberculosisBeijing Chest Hospital, Capital Medical UniversityRecruiting
NCT07575061Recruiting
—
A 15-year Cohort Study on Risk Factors of Mortality in Patients With Intestinal...Beijing Chest Hospital, C...
NCT07576725
Low Dose, Reduced Frequency Nivolumab for the Treatment of Unresectable or Metastatic Cancer, AFFORD IO TrialFred Hutchinson Cancer CenterNot Yet RecruitingPhase 2
NCT07576725Not Yet Recruiting
Phase 2
Low Dose, Reduced Frequency Nivolumab for the Treatment of Unresectable or Metas...Fred Hutchinson Cancer Ce...
NCT07575100
MAITLAND MOBILIZATION VERSUS THERAPEUTIC ULTRASOUND ON TRISMUS FOLLOWING THIRD MOLAR SURGERYCairo UniversityCompletedNot Applicable
NCT07575100Completed
Not Applicable
MAITLAND MOBILIZATION VERSUS THERAPEUTIC ULTRASOUND ON TRISMUS FOLLOWING THIRD M...Cairo University
NCT07576374
Specificities of Atypical Non AutoImmune Diabetes (ANAID) in the French West IndiesCentre Hospitalier Universitaire de la GuadeloupeNot Yet Recruiting
NCT07576374Not Yet Recruiting
—
Specificities of Atypical Non AutoImmune Diabetes (ANAID) in the French West Ind...Centre Hospitalier Univer...
NCT07575191
Safety and Performance of a Novel Infusion Catheter System for Peri/Intratumoral Gemcitabine Delivery in Patients With Pancreatic CancerSmartwise Sweden ABNot Yet RecruitingPhase 1
NCT07575191Not Yet Recruiting
Phase 1
Safety and Performance of a Novel Infusion Catheter System for Peri/Intratumoral...Smartwise Sweden AB
NCT07574463
Adaptive Digital Exercise Rehabilitation for Children After CHD SurgeryBeijing Children's HospitalNot Yet RecruitingNot Applicable
NCT07574463Not Yet Recruiting
Not Applicable
Adaptive Digital Exercise Rehabilitation for Children After CHD SurgeryBeijing Children's Hospit...
NCT07576023
A 4-weeks Comparative Study of Cosmetic Product Versus Standard Medical Care in Subjects With Seborrheic DermatitisPierre Fabre Dermo CosmetiqueCompletedNot Applicable
NCT07576023Completed
Not Applicable
A 4-weeks Comparative Study of Cosmetic Product Versus Standard Medical Care in...Pierre Fabre Dermo Cosmet...
NCT07576179
Plantar Intrinsic Muscles Exercises and Three-dimensional Ankle Foot Exercises Comparative Effect in DPNRiphah International UniversityRecruitingNot Applicable
NCT07576179Recruiting
Not Applicable
Plantar Intrinsic Muscles Exercises and Three-dimensional Ankle Foot Exercises C...Riphah International Univ...
NCT07574970
A COMBINATION OF RECTAL INDOMETHACIN AND COLD -WATER EXPOSURE OF THE AMPULLA AFTER ERCP IS SUPERIOR TO RECTAL INDOMETHACIN ALONE IN REDUCING THE INCIDENCE OF POST-ERCP PANCREATITIS - A PILOT RCT IN INDIAN POPULATIONAsian Institute of Gastroenterology, IndiaRecruiting
NCT07574970Recruiting
—
A COMBINATION OF RECTAL INDOMETHACIN AND COLD -WATER EXPOSURE OF THE AMPULLA AFT...Asian Institute of Gastro...
NCT07575360
PT-GBD to EUS-GBD Conversion Versus Standard Management in High-Risk Acute Cholecystitis PatientsUniversity of BolognaCompleted
NCT07575360Completed
—
PT-GBD to EUS-GBD Conversion Versus Standard Management in High-Risk Acute Chole...University of Bologna
NCT07574515
The Effect of Nasogastric Tube Placement on Complications in Patients With Small Bowel Obstruction - the SBO-TUBE Randomized Controlled TrialLinkoeping UniversityNot Yet RecruitingNot Applicable
NCT07574515Not Yet Recruiting
Not Applicable
The Effect of Nasogastric Tube Placement on Complications in Patients With Small...Linkoeping University
NCT07576998
PHIL™ Middle Meningeal Artery Embolization for First-Line Treatment of Chronic Subdural Hematoma IDE TrialMicrovention-Terumo, Inc.Not Yet RecruitingNot Applicable
NCT07576998Not Yet Recruiting
Not Applicable
PHIL™ Middle Meningeal Artery Embolization for First-Line Treatment of Chronic S...Microvention-Terumo, Inc.
NCT07575893
CD30 CAR-T Cells for Low Risk Relapsed Classical Hodgkin LymphomaMemorial Sloan Kettering Cancer CenterNot Yet RecruitingPhase 1
NCT07575893Not Yet Recruiting
Phase 1
CD30 CAR-T Cells for Low Risk Relapsed Classical Hodgkin LymphomaMemorial Sloan Kettering...
NCT07576842
Testing the Feasibility of Different HPV Screening and Care Strategies for Women Living With HIVBeth Israel Deaconess Medical CenterNot Yet RecruitingNot Applicable
NCT07576842Not Yet Recruiting
Not Applicable
Testing the Feasibility of Different HPV Screening and Care Strategies for Women...Beth Israel Deaconess Med...
NCT07576049
COLORECTAL CANCER: SINGLE CENTER EXPERIENCEUniversity of Roma La SapienzaEnrolling By Invitation
NCT07576049Enrolling By Invitation
—
COLORECTAL CANCER: SINGLE CENTER EXPERIENCEUniversity of Roma La Sap...
NCT07575750
Efficacy of Transcutaneous Auricular Vagus Nerve Stimulation (taVNS) in Aromatase Inhibitor-induced Arthralgia (AIA): a Phase 2, Randomized, Monocentric, taVNS Versus Sham, Double BlindInstitut Cancerologie de l'OuestNot Yet RecruitingNot Applicable
NCT07575750Not Yet Recruiting
Not Applicable
Efficacy of Transcutaneous Auricular Vagus Nerve Stimulation (taVNS) in Aromatas...Institut Cancerologie de...
NCT07574580
Non-Invasive Vagus Nerve Stimulation in Patients With Acute Burn InjuriesFenerbahce UniversityEnrolling By InvitationNot Applicable
NCT07574580Enrolling By Invitation
Not Applicable
Non-Invasive Vagus Nerve Stimulation in Patients With Acute Burn InjuriesFenerbahce University
Result Breakdown
Not yet recruiting11 (55%)
Recruiting3 (15%)
Completed3 (15%)
Enrolling by invitation2 (10%)
Active, not recruiting1 (5%)
not_applicable11 (55%)
Not Specified6 (30%)
Phase 12 (10%)
Phase 21 (5%)